The Second Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan.
Department of Surgery 1, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan.
Medicina (Kaunas). 2022 Feb 24;58(3):347. doi: 10.3390/medicina58030347.
Mortality and morbidity remain high following transcatheter aortic valve replacement (TAVR) in dialysis patients or those with low left ventricular ejection fraction. Therapeutic strategy for those with these comorbidities remains unestablished. We had a dialysis patient with peripheral artery disease and low left ventricular ejection fraction, who received successfully scheduled trans-apical TAVR following sufficient reverse remodeling by 3-month optimal medical therapy. Our strategy should be validated in a larger robust cohort.
经导管主动脉瓣置换术（TAVR）后，透析患者或左心室射血分数低的患者死亡率和发病率仍然很高。对于这些合并症患者的治疗策略尚未确定。我们有一位患有外周动脉疾病和左心室射血分数低的透析患者，在经过 3 个月的最佳药物治疗充分逆转重构后，成功接受了经心尖 TAVR 治疗。我们的策略应在更大的稳健队列中得到验证。
